| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 49,200 | 25 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | 25 Apr 2023 | 1 | $0 | 4 | Director | 08 May 2023, 21:53 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 09 Mar 2023 | 1 | +$46,148 | 4 | Director | 13 Mar 2023, 07:59 |
| ZVRA | KEMPHARM, INC | 28 Jun 2022 | 1 | $0 | 4 | Director | 30 Jun 2022, 17:19 |
| ZVRA | KEMPHARM, INC | 18 May 2022 | 4 | +$24,780 | 4 | Director | 18 May 2022, 19:01 |
| ZVRA | KEMPHARM, INC | 01 Dec 2021 | 1 | +$21,100 | 4 | Director | 01 Dec 2021, 15:28 |
| ZVRA | KEMPHARM, INC | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 08:35 |